Herein, we reported the discovery of these IDs as potential anti-CRC agents and explored their underlying anticancer mechanisms including BRD4 inhibition assay, the effects on cell cycle, cell apoptosis as well as the expression levels of c-Myc and Bcl-2 in CRC cell lines in vitro. Here, MYC is linked to colorectal carcinoma.